mRNA |
LY-2183240 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
3e-08 |
mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
3e-08 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
3e-08 |
mRNA |
BX-912 |
GDSC1000 |
pan-cancer |
AAC |
0.18 |
4e-08 |
mRNA |
QL-XI-92 |
GDSC1000 |
pan-cancer |
AAC |
0.19 |
5e-08 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
6e-08 |
mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
6e-08 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
7e-08 |
mRNA |
SN-38 |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
1e-07 |
mRNA |
prima-1 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
2e-07 |